Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia

PurposeDespite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-based treatment.MethodsThe study cohort consisted of...

Full description

Bibliographic Details
Main Authors: Hyun Jin Oh, Mun Sung Cho, Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, Hack-Ki Kim
Format: Article
Language:English
Published: Korean Pediatric Society 2013-08-01
Series:Korean Journal of Pediatrics
Subjects:
Chronic myelogenous leukemia
Imatinib mesylate
Allogeneic transplantation
Children
Online Access:http://kjp.or.kr/upload/pdf/kjped-56-343.pdf

Similar Items

Similar Items